Life Sciences Investment Banking

An experienced team in a vibrant sector.

Raymond James Life Sciences practice provides comprehensive advisory and financing capabilities to innovative businesses in the biotechnology, specialty pharmaceutical and generic pharmaceutical sectors. Companies within the biopharma industry continue to face the disruptive forces that require them to tailor their strategies in the continually evolving business environment. Our team provides our clients with solutions based on our deep relationships with company management teams as well as venture, private equity and public market investors.

Life Sciences Subsector Expertise

  • Biotechnology
  • Pharmaceutical Services
  • Pharmaceutical Technology
  • Pharmaceutical Supply Chain
  • Specialty Pharmaceuticals

Senior Banking Team

Doug Brown
Head of Healthcare
Charlotte
   
Read Bio
Stu Barich
Stuart Barich
Managing Director
New York
   
Read Bio
Mike Drendel
Managing Director
Charlotte
 
Eric Francois
Managing Director
New York
   
Read Bio
Brian Gleason
Brian Gleason
Managing Director
New York
   
Marwan Kubursi
Marwan Kubursi
Managing Director
Toronto
   
Don Matz
Managing Director
Charlotte
   
Read Bio
David Stubbs
David Stubbs
Managing Director
London
   
Read Bio
Juan Carlos Barreto
Director
Charlotte
   
Deborah Gerewitz
Deborah Gerewitz
Director
New York
   
Read Bio
Allena Baker
Vice President
Austin
   
Read Bio
Sam Copman
Vice President
Charlotte
   
Read Bio
Matthew Karpf
Vice President
New York
   
Read Bio
Lucas Lee
Lucas Lee
Vice President
New York
   
Kevin Phelan
Vice President
Charlotte
   
Read Bio

Transaction History

Transaction history may include a transaction completed by a Raymond James banker while at a former firm.

Recent News

Investment Banking  |  April 24, 2024

Raymond James adds to growing private capital advisory business hiring four senior bankers

Read more about Raymond James adds to growing private capital advisory business hiring four senior bankers
Equity Research  |  April 16, 2024

Raymond James hires Tim Thein as senior industrial machinery analyst

Read more about Raymond James hires Tim Thein as senior industrial machinery analyst
Capital Markets  |  February 26, 2024

Raymond James strengthens its capital markets platform with two leadership appointments

Read more about Raymond James strengthens its capital markets platform with two leadership appointments